Note: Ingredients listed on restricted chemical lists
EC/CAS
200-559-2/63-42-3
Name of the chemical
Lactose C12H22O11
Concentration
*
General Information
Version
3
Revision date
2023-03-28
Product name
Doxorubicin Hydrochloride Powder for Solution for
Product name
Doxorubicin Hydrochloride Powder for Solution for
Identification on the label/Trade name
Not applicable
Chemical name
Mixture
Icons in SDS
Company Information
company name
Hospira, A Pfizer Company
e-mail address of the competent person responsible for the Safety Data Sheet
pfizer-MSDS@pfizer.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H340, H350, H360FD, H402, H412
Hazard statements
Code
Statements
H340
May cause genetic defects
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
GHS - Classification Regulated
Physical hazards
Combustible Dust
Signal word
Danger
Hazard statements
H340 - May cause genetic defects H350 - May cause cancer H360FD - May damage fertility. May damage the unborn child H412 - Harmful to aquatic life with long lasting effects
Precautionary statements
P201 - Obtain special instructions before use P202 - Do not handle until all safety precautions have been read and understood P281 - Use personal protective equipment as required P308 + P313 - IF exposed or concerned: Get medical attention/advice P405 - Store locked up P501 - Dispose of contents/container in accordance with all local and national regulations
Other hazards
An Occupational Exposure Value has been established for one or more of the ingredients (see Section 8). Note: This document has been prepared in accordance with standards for workplace safety, which require the inclusion of all known hazards of the product or its ingredients regardless of the potential risk. The precautionary statements and warnings included may not apply in all cases. Your needs may vary depending upon the potential for exposure in your workplace.
